Driehaus Capital Management LLC Adverum Biotechnologies, Inc. Transaction History

Driehaus Capital Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$2.87 - $5.92 $5.37 Million - $11.1 Million	-1,872,224 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$4.5 - $7.6 $530,424 - $895,827	-117,872 Reduced 5.92%	1,872,224 $11.3 Million
Q2 2018 Aug 14, 2018	BUY	$5.3 - $6.9 $631,532 - $822,183	119,157 Added 6.37%	1,990,096 $10.5 Million
Q1 2018 May 15, 2018	BUY	$3.65 - $7.95 $6.83 Million - $14.9 Million	1,870,939 New	1,870,939 $10.9 Million

524K

Ticker ADVM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,333,600
Market Cap $471M
Description
Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration an...

Get notified when there are updates to the investment portfolio of Driehaus Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Driehaus Capital Management LLC with notifications on news.